Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Clevidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms VELOCITY
- Sponsors The Medicines Company
- 27 Aug 2008 Results published in the Annals of Emergency Medicine, as reported by a The Medicines Company media release.
- 02 Feb 2007 Status changed from recruiting to completed.
- 13 Sep 2006 New trial record.